ZJYLNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends September 30
Jin Medical International Ltd.
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Feb 10, 2026
$2.11+0.03 (+1.44%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 211.0
- Dividend yield
- –
Share price
−$4.47 (−67.95%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Jin Medical International Ltd. saw revenue fall 12.0% to $20.69M over fiscal 2025. Operating income fell 83.3% to $608.18K, moving the operating margin from 15.5% to 2.9%. Free cash flow was -$3.73M.
Revenue
$20.69M
-12.0% vs. a year earlier
Operating income
$608.18K
-83.3% vs. a year earlier
Free cash flow
-$3.73M
FY2025
EPS, diluted
$0.01
-50.0% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Sep 30, 2025
Valuation
- Market cap
- –
- P/E ratio
- 211.0
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $20.69M
- Net income
- $1.19M
- EPS, diluted
- $0.01
- Free cash flow
- -$3.73M
Six years at a glance
Fiscal years 2020 to 2025, USD
Revenue
$20.69M-12.0% YoY
Gross profit
$6.04M-36.4% YoY
Operating income
$608.18K-83.3% YoY
Net income
$1.19M-67.6% YoY
EPS, diluted
$0.01-50.0% YoY
Free cash flow
-$3.73M
Reported period